CClinicalTrials.gg
CompletedNCT06763042Updated Jan 8, 2025

Usability and Utility of Mindfulness-based Life Management Social Robots for Children and Adolescents in the Long-term Treatment

An interventional study of Mindfulness-based Life Management Social Robots in Pediatric Cancer and Psychology, Child, sponsored by Samsung Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-01-08.

Sponsored by Samsung Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
6 Years to 12 Years
Sex
All
01

Study summary

The purpose of this study is to apply social robot-based mindfulness-based life management content to pediatric and adolescent patients in the long-term disease treatment process and to assess usability and effectiveness of the social robot-based mindfulness-based life management content.

[Question 1] Effectiveness: Was the content on social robots effective in psychological adaptation of pediatric and adolescent patients?

[Question 2] Usability: Is there any difficulty in interacting through social robots applied in the hospital environment?

The participants conduct a preliminary survey and use robot content at least 10 times for the two weeks. Afterwards, follow-up surveys and in-depth interviews will be conducted.

Read the detailed description

The purpose of this study is to apply social robot-based mindfulness-based life management content to pediatric and adolescent patients in the long-term disease treatment process and to assess usability and effectiveness of the social robot-based mindfulness-based life management content.

[Intervention]

  • Intervention period: 15-20 minutes or more per day for 14 days (at least 10 times in 2 weeks)
  • Content: Life management content for mindfulness play and disease understanding
  • Method of provision: Robot interaction using chatbot and remote conversation (mindfulness-based living management content and remote content will be provided for a total of 15 to 20 minutes)

[Question 1] Effectiveness: Was the content on social robots effective in psychological adaptation of pediatric and adolescent patients?

(Measure) Pre-post comparison of survey result values

  • Child Emotional and Behavioral Disorder Assessment Scale (Korea-Child Behavior Checklist: K-CBCL) ② Child and Youth Mindfulness Scale (Korean Child and Adolescent Mindfulness Measure: K-CAMM) ③ Child and Youth Optimism Scale (The Children's Life Orientation Test: C-LOT)

[Question 2] Usability: Is there any difficulty in interacting through social robots applied in the hospital environment?

(Measure) User Experience Questionnaire(UEQ), In-depth Interview

02

Conditions studied

  • Pediatric Cancer
  • Psychology, Child
03

In context

Lead sponsor

Samsung Medical Center is the lead sponsor of 980 studies on the registry; 146 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients aged 6 to 12 years old who is being treated after the diagnosis of a severe or chronic disease
  • Pediatric patients who need hospital treatment, including inpatient or outpatient treatment, for more than 3 months
  • Pediatric patients with a level of communication that can be understood and agreed to in this study

Exclusion criteria

Exclusion Criteria:

  • Those who disagree with this study
  • Pediatric patients who are judged to be difficult to interact with robots due to communication difficulties
  • Pediatric patients who has been diagnosed with or is being treated for mental illness with psychotic characteristics
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Groups that use the Mindfulness-based Life Management Social Robots

    Intervention period: 15-20 minutes or more per day for 14 days (at least 10 times in 2 weeks) Content: Life management content for mindfulness play and disease understanding Method of provision: Robot interaction using chatbot and remote conversation (mindfulness-based living management content and remote content will be provided for a total of 15 to 20 minutes)

    Device: Mindfulness-based Life Management Social Robots

Interventions

  • DeviceMindfulness-based Life Management Social Robots

    Mindfulness-based life management contents for pediatric patients operated by Social Robots

06

What researchers measure

Primary outcomes

  1. Evaluation Scale of Child Emotional and Behavioral Disorders

    Measure and compare the score of Korea-Child Behavior Checklist (K-CBCL) before and after intervention. Change in psychological adaptation scores among pediatric and adolescent patients as measured by a validated psychological adaptation questionnaire. The questionnaire includes subscales for emotional regulation, coping mechanisms, and social engagement. Results will be reported as mean changes in scores from baseline to 14 days.

    Time frame: 14 days

  2. Measurement of Mindfulness Scale for Children and Adolescents

    Measure and compare the score of Korean Child and Adolescent Mindfulness Measure (K-CAMM) before and after intervention. Change in psychological adaptation scores among pediatric and adolescent patients as measured by a validated psychological adaptation questionnaire. The questionnaire includes subscales for emotional regulation, coping mechanisms, and social engagement. Results will be reported as mean changes in scores from baseline to 14 days.

    Time frame: 14 days

  3. Measurement of optimism in children and adolescents

    Measure and compare the score of The Children's Life Orientation Test (CLOT) before and after intervention. Change in psychological adaptation scores among pediatric and adolescent patients as measured by a validated psychological adaptation questionnaire. The questionnaire includes subscales for emotional regulation, coping mechanisms, and social engagement. Results will be reported as mean changes in scores from baseline to 14 days.

    Time frame: 14 days

Secondary outcomes

  1. Measurement of Measurement User Experience Questionnaire Short Version (UEQs)

    Measurement of Measurement User Experience Questionnaire Short Version (UEQs) after intervention. Number of reported difficulties in interacting with the social robot, as assessed by a semi-structured usability survey. The survey includes items on ease of interaction, clarity of instructions, and overall user satisfaction. Responses will be quantified on a Likert scale (1 = very difficult, 5 = very easy).

    Time frame: 14 days

  2. In-depth interview

    Interviews with study subjects based on the overall contents of the study

    Time frame: 14 days

07

Study locations

1 site
  • Samsung Medical Centre
    Seoul, 06351, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06763042
Lead sponsor
Samsung Medical Center
Responsible party
Sponsor
First posted
Jan 8, 2025
Start date
Sep 20, 2023
Primary completion
Dec 31, 2023
Completion
Jan 31, 2024
Last update
Jan 8, 2025

Study contacts

Meong Hi Son
principal investigator · Samsung Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion